Ana Velasco-Iglesias

A Multicentric, Open-Label, Randomized, Comparative Clinical Trial of Two Different Doses of Expanded hBM-MSCs Plus Biomaterial versus Iliac Crest Autograft, for Bone Healing in Nonunions after Long Bone Fractures: Study Protocol

F. Catani, I. Marzi, E. Gómez-Barrena, 2018, Stem cells international.

A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia.

J. Alcamí, M. Pérez-Olmeda, E. Muñiz‐Díaz, 2021, The Journal of clinical investigation.

Evaluation of convalescent plasma versus standard of care for the treatment of COVID-19 in hospitalized patients: study protocol for a phase 2 randomized, open-label, controlled, multicenter trial

A. Fernández-Cruz, R. M. de Molina, J. Bueno, 2020, Trials.

Pathogen reduction with methylene blue does not have an impact on the clinical effectiveness of COVID‐19 convalescent plasma

M. Pérez-Olmeda, J. G. García Erce, C. Avendaño-Solá, 2023, Vox Sanguinis.